The Postoperative Bacteriuria Score A New Way to Predict Nosocomial Infection After Prostate Surgery

Girou, Emmanuelle; Rioux, C.; Brun‐Buisson, Christian; Lobel, Bernard

doi:10.1086/506398

Cited by 35 publications

(30 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…After an aerobic incubation at 37˚C, the plates showing significant growth as per the Kass count (single species count of more than 10 5 organisms per ml of urine) were processed further and the isolates were identified up to the species level by using standard biochemical tests [5][6][7][8]. Antibiotic sensitivity testing was done by the Kirby Bauer disc diffusion method as per CLSI guidelines [9,10].…”

Section: Methodsmentioning

confidence: 99%

Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance

Sabharwal

Sharma

2015

JCDR

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance

Sabharwal

Sharma

2015

JCDR

View full text Add to dashboard Cite

“…The bacterial count was expressed as colony forming units (CFU) per milliliter (ml). Following the recommendations of Kass in distinguish in the infection from contamination, significant bacteriuria was defined as culture of a single bacterial species from the urine sample at a concentration of >10 5 CFU/ml [11].…”

Section: Direct Microscopymentioning

confidence: 99%

Changing trends in resistance pattern as an alarm by bacteria before it’s too late to treat

Gupta¹

2013

IOSR-JDMS

View full text Add to dashboard Cite

show abstract

“…This is not supported by our study, where duration of the surgery was not a risk factor (p=0.332). This is supported by Girou et al 31 Urological departments should be encouraged to monitor the susceptibility of pathogens causing NAUTI in order to overcome the possibility of infection. Overall, the risk factors fall into three general categories: patient-related risk factors, device-related risk factors, and risk factors related to catheter insertion and care.…”

Section: Closed Drainagementioning

confidence: 87%

“…2 Several authors have, however, reported that TURP represents a risk factor for NAUTI. 30,31 The duration of surgery has long been implicated in nosocomial infections. This is not supported by our study, where duration of the surgery was not a risk factor (p=0.332).…”

Section: Closed Drainagementioning

confidence: 99%

Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control

Bouassida¹,

Jaidane²,

Bouallègue³

et al. 2016

CUAJ

View full text Add to dashboard Cite

Introduction: Our goal was to investigate the prevalence and antibiogram pattern of extended spectrum beta-lactamase (ESBL) production among uropathogens using isolates from urine samples collected at the Department of Urology in the Sahloul Hospital, Tunisia We also aimed to identify the risk factors for nosocomial urinary tract infections (UTIs) in patients who underwent transurethral resection of the prostate (TURP) and the measures for infection control. Methods: Laboratory records of a five-year period from January 2004 to December 2008 were submitted for retrospective analysis to determine the incidence of ESBL infections. A total of 276 isolates were collected. A case-control study involving comparisons between two groups of patients who underwent TURP was performed to determine the risk factors for ESBL infection. Group 1, designated case subjects, included 51 patients with nosocomial UTI after TURP. Group 2, designated control subjects, consisted of 58 randomly selected patients who underwent TURP without nosocomial UTI in the same period. Factors suspected to be implicated in the emergence of ESBL infection were compared between the two groups in order to identify risk factors for infection. A univariate regression analysis was performed, followed by a multivariate one. Results: The annual prevalence of ESBL infection ranged from 1.3-2.5%. After performing univariate and multivariate regression analysis, the main risk factors for ESBL infections were identified as: use of antibiotics the year preceding the admission, duration of catheter use, and bladder washout (p=0.012, p=0.019, and p<0.001. Conclusions: Urologists have to perform a good hemostasis, especially in endoscopic resections, in order to avoid bladder irrigation and bladder washout and to reduce the time of bladder catheterization, which is a strong risk factor of nosocomial UTIs. IntroductionHospital infections have become a growing healthcare challenge in recent decades and serious concerns have been expressed over the rise in antimicrobial resistance among pathogens causing hospital-acquired infections. Nosocomially acquired urinary tract infection (NAUTI) is one of the most common hospital-acquired infections. 2,3This infection is not already present or incubating at the time of admission, but is acquired during hospital stay. Its definition requires a 48-hour delay after admission before symptoms appear.1,4,5 NAUTI has become one of the most important quality parameters for urological surgery. The problem is further exacerbated by the emergence of drug resistance among uropathogens in the form of extended spectrum beta-lactamase (ESBL) production. In fact, the first outbreak of ESBL-producing organisms was reported in 1983 in Germany 1 and involved chromosomal-or plasmid-mediated beta-lactamases (enzymes that cleave the beta-lactam ring) that had mutated from pre-existing broad-spectrum beta-lactamases as a consequence of the extensive use of third-generation cephalosporins and aztreonam.6 Those ESBL-producing pathogens are now...

show abstract

The Postoperative Bacteriuria Score A New Way to Predict Nosocomial Infection After Prostate Surgery

Abstract: POBS could be used to distinguish patients at risk of developing infection after TURP. This information might be useful for implementing selective prevention measures or for adjustment for differences in nosocomial infection rates when comparing data between urology centers.

Cited by 35 publications

References 31 publications

Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance

Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance

Changing trends in resistance pattern as an alarm by bacteria before it’s too late to treat

Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control

Contact Info

Product

Resources

About